AstraZeneca PLC is 53.4x more valuable than Cogent Biosciences, Inc. by market capitalization ($286.27 B vs $5.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COGT | AZN |
|---|---|---|
| Market cap | $5.36 B | $286.27 B |
| US-listed rank | #1334 | #45 |
| Net income (latest FY) | -$328.94M | - |
| SEC filings | 595 | 1,004 |
AstraZeneca PLC is 53.4x more valuable than Cogent Biosciences, Inc. by market capitalization ($286.27 B vs $5.36 B).
Full pages: Cogent Biosciences, Inc. and AstraZeneca PLC, or browse the full rankings.